If you are looking for another refractive option to reduce the need for glasses or contacts, look no further. For the right candidate, the EVO ICL, also called an Implantable Collamer® Lens, is a refractive implant that can correct common vision issues like myopia (nearsightedness) with or without astigmatism. Unlike some vision correction options, the EVO ICL is an additive technology that corrects vision without the removal of any corneal tissue. This recent FDA approval of EVO Implantable Collamer Lens brings another option for an estimated 100 million U.S. adults ages 21 to 45 are that are potential candidates for the implantable lens that corrects distance vision according to STAAR Surgical Company.
In May of 2022, our very own Dr. Matthew Rauen had the opportunity to place Iowa’s FIRST EVO Implantable Collamer Lens (ICL) for Wolfe Eye
Clinic patient, Carolina. The EVO lens provided correction for her myopia and was deemed a great option in helping Carolina to reach her vision goals. Myopia, also known as nearsightedness, is the most common vision disorder in individuals around the world and many of those patients aspire for vision correction in the distance. According to the American Optometric Association, 30% of the U.S. population is affected by myopia.
EVO ICL may be suited for a wide variety of people. Ideal candidates for EVO ICL are aged 21 to 45 with nearsightedness, with or without astigmatism and have maintained a stable prescription for at least one year. Patients find the benefits of the EVO ICL to be:
If you are seeking a solution to decrease or eliminate the cost and frustration of traditional contacts or glasses, EVO ICL may be your answer. Contact us to discuss if EVO ICL is right for you.
Give us a call today to learn more at (833) 532-8809.
With more than 40 locations throughout Iowa, expert eye care is always close to home.
Whether you need a routine eye exam or advanced surgical care, our team is here to help you see your best.
